Analysts at Barclays upgraded shares of Omnicare Inc. (NYSE:OCR) from an “equal weight” rating to an “overweight” rating in a research note on Thursday. They now have a $83.00 price target on the stock, up previously from $67.00. On Thursday shares of Omnicare Inc. (NYSE:OCR) closed at $75.41. Company’s sales growth for last 5 years was -0.60% and EPS growth for next 5 years is recorded as 15.00%.

NuVasive (NASDAQ:NUVA) was upgraded by stock analysts at RBC Capital from a “sector perform” rating to an “outperform” rating in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm currently has a $56.00 price target on the stock, up from their previous price target of $45.00. RBC Capital’s price objective suggests a potential upside of 15.49% from the stock’s previous close. NuVasive, Inc. (NASDAQ:NUVA) in last trading activity advanced 3.92% to close at $50.39. Company weekly performance is 6.85% while its quarterly performance stands at 39.93%. NuVasive, Inc. (NASDAQ:NUVA) is 2.84% away from its 52 week high.

Jefferies Group upgraded shares of Eli Lilly and (NYSE:LLY) from a hold rating to a buy rating in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm currently has $80.00 price target on the stock, up from their previous price target of $75.00. On last trading day Eli Lilly and Company (NYSE:LLY) advanced 2.37% to close at $70.87. Its volatility for the week is 2.21% while volatility for the month is 2.15%. LLY’s sales growth for past 5 years was 2.60% and its EPS growth for past 5 years was 33.80%. Eli Lilly and Company (NYSE:LLY) monthly performance is -2.69%.

Universal Health Services (NYSE:UHS) was downgraded by research analysts at Barclays from an “overweight” rating to an “equal weight” rating in a report released on Thursday, TheFlyOnTheWall.com reports. Universal Health Services Inc. (NYSE:UHS) has 0.60% insider ownership while its institutional ownership stands at 93.80%. In last trading activity company’s stock closed at $113.14.